StemCellsAwarenessDay-StudentPhoto (IMAGE)
Caption
UC San Diego has received a $7.4 million grant to support the development of a first-of-its-kind stem cell-based gene therapy for Friedreich’s ataxia.
Credit
Kyle Dykes/UC San Diego Health Sciences
Usage Restrictions
use photo credit
License
Original content